← Back


Friday, 31 October 2014

The updated map of ICTS includes the CIBER-BBN platform NANBIOSIS

Prof. Laura M. Lechuga is among the scientific coordinators of the 29 units shaping this platform, which allows for development of a therapeutic agent to reach its preclinical validation.

The new map of Scientific-Technological Infrastructures (ICTS), recently updated by the Spanish Consejo de Politica Cientifica, Tecnológica y de Innovación (Council for Science Policy, Technology and Innovation), includes the integrated infrastructure for the production and characterization of nanomaterials, biomaterials and biomedical systems (NANBIOSIS). The new ICTS is formed by the CIBER-BBN and the Centro de Cirugia de Minima Invasión Jesus Usón (CCMIJU). NANBIOSIS has locations in Zaragoza, Badajoz, Barcelona, Caceres, Madrid, Valencia and Alava and its potential is open to the scientific community.

NANBIOSIS has a scientific and cutting edge technological infrastructure with outstanding scientific coordinators. Among them is CSIC researcher and Group Leader at ICN2, Prof. Laura M. Lechuga. NANBIOSIS consists of 28 coordinated units that offer a complementary service including the design, production of biomaterials and nanomaterials and characterization of these bio and nanomaterials, tissues, medical devices and systems. It works with a physico-chemical, functional, toxicological and biological approach, including pre-clinical validation, focused on biomedical applications. The ICN2 NanoBioSensors and Bionalytical Applications Group plays a key role in this platform.

Information via CIBER-bbn.